COVID-19 vaccine developed at University of Alberta proceeding to clinical trials

Adam Lachacz - 09 March 2021

An Alberta-developed COVID-19 vaccine using new technology is one step closer to starting clinical trials.

John Lewis, University of Alberta professor and CEO of Entos Pharmaceuticals, has shipped a vaccine for further testing to the Canadian Centre for Vaccinology in Halifax – a step forward toward its Health Canada approval. The made-in-Alberta COVID-19 vaccine will commence its Health Canada Phase 1 human clinical trial with the aim of moving it to a larger Phase 2 trial by late spring to test its efficacy.

“Its been a long road,” Lewis said in an interview with CTV News Edmonton. “I am definitely enthusiastic about where it is going from here.”